Announcements Trials
Browse Landscape

Phase

Phase 2 75Phase 1/2 11Phase 1 11Phase EARLY_PHASE1 7Phase 3 6Phase 4 3Phase NA 2

Status

Recruiting 3Active not recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 19OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 5Neoplasm Metastasis 1Breast Cancer Female 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 166Gemcitabine 165Oxaliplatin 162Carboplatin 160Paclitaxel 152Leucovorin 122Drug Therapy 118Dexamethasone 118Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 56Neoadjuvant Therapy 53Lenalidomide 52Letrozole 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × OTHER × abemaciclib × Clear all
NCT06585969 2026-02-12

DISCORDANT

Danish Breast Cancer Cooperative Group

Phase 3 Withdrawn
Breast

Breast Neoplasms

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting
123 enrolled
Breast

Breast Cancer Female

NCT07190443 2025-09-29

AURA

Japanese Foundation for Cancer Research

Phase 3 Recruiting
290 enrolled
Breast

Breast Neoplasms

NCT04158362 2025-09-22

AMBRE

UNICANCER

Phase 3 Active not recruiting
180 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT06341621 2024-04-10

Rainbow

Fudan University

Phase 3 Recruiting
1,900 enrolled
Breast

Breast Neoplasms

NCT05891093 2024-02-08

Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)

Fudan University

Phase 3 Recruiting
766 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡